Últimas noticias sobre ARM Holdings (NASDAQ:ARM) Bolsa

ARM HOLDINGS PLC-ADR

ARM Holdings

Arm Holdings is the intellectual property owner and developer of the ARM architecture, which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allow them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Both off-the-shelf and architectural customers pay a royalty fee per chip shipped.

Cdg,Airport,,Paris,-,12 - 22 - 18:,Aws,Amazon,Cloud,Services,Brand

News

Tech

Media

AMZN

GOOGL

INTC

MSFT

NVDA

Amazon refuerza su apuesta por la IA con el chip Graviton4, buscando reducir dependencia de Nvidia y dominar la nube con tecnología propia.

Amazon prepara el Graviton4 para competir con Nvidia, Intel y AMD en plena revolución de la IA

Nvidia shutterstock_2567997995

Government

Regulations

AVGO

MRVL

Las acciones de Nvidia y otras tecnológicas suben tras el acuerdo EE.UU.-China para reducir aranceles durante 90 días.

Nvidia y semiconductores suben tras tregua EE.UU.-China: alivio arancelario impulsa el sector

Small,Semiconductor,On,A,Circuit,Board.,Extreme,Closeup,Of,A

Movers

BABA

Las acciones de Nvidia, AMD y otras tecnológicas suben tras los buenos resultados de Meta y Microsoft. Mira quién lidera el repunte.

Las acciones de semiconductores se disparan tras los sólidos resultados de Meta y Microsoft

Arm Holdings plc - American Depositary Shares

ARM Holdings PLC

Un Monde International Worldwide Ltd

ARMOR ELECTRIC INC by Armor Electric, Inc.

Leverage Shares 2X Long ARM Daily ETF

Precidian ETFs Trust Arm Holdings PLC ADRhedged

Aramark

Current Energy and Renewables Corp

Aris Mining Corp

ARMOR

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals Inc

Exchange Listed Funds Trust Armor US Equity Index ETF

ETF Opportunities Trust T-REX 2X Long ARM Daily Target ETF

Arma Services Inc

WIIM

LEU stock has given up its prior loss. Centrus Energy shares were trading lower after JP Morgan inititaed coverage on the stock with a Neutral rating and announced a price target of $148.

B. Riley Securities analyst Madison El-Saadi initiates coverage on Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) with a Buy rating and announces Price Target of $21.

Price Target

Initiation

Analyst Ratings

CAPR

B. Riley Securities Initiates Coverage On Capricor Therapeutics with Buy Rating, Announces Price Target of $21

ARTL

Artelo Biosciences shares are trading higher after the company announced it entered into a private placement to generate proceeds of $1.425 million.

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/06/2025-06-26_07h43_31.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Room In AI Trade</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-new-nvidia-high-ai-trade-nvda-mc-06262025">click here</a> for an enlarged chart of NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Note the following:
<ul class="wp-block-list">
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of NVDA stock is being used to illustrate the point.</li>
<li>The chart shows NVDA stock broke out above zone 1.&nbsp; Zone 1 was previously resistance and is now support.</li>
<li>The chart shows on April 9 we gave a signal to buy NVDA stock naming NVDA one of the top stocks to buy on the dip.  On April 9, NVDA stock traded in the range of $97.53 &#8211; $115.10.</li>
<li>Yesterday, NVDA stock made a new high.  NVDA is trading at $156.80 as of this writing in the premarket.  At its low after Liberation Day, NVDA stock fell to $86.62.  The consensus in the market at that time was the AI trade was over.  However, we remained steady fast in our conviction that the AI trade had a long way to go.  As full disclosure, we gave signals initiating several trade-around positions, including one on NVDA as shown on the chart. Trade around positioning is a technique billionaires and hedge funds use to dramatically increase returns while reducing risks. </li>
<li>NVDA stock breaking to a new high shows that our call that money is to be made in AI all the way to 2030 is proving spot on.</li>
<li>The sentiment on Wall Street is already extremely bullish.&nbsp; You would think it is difficult to add more bullishness to extreme bullishness, but that is exactly what President Trump has accomplished.&nbsp; President Trump's actions aim to take away the Federal Reserve's independence sooner than expected.&nbsp; Here are the key points: 
<ul class="wp-block-list">
<li>Powell's term expires in 11 months.</li>
<li>Traditionally, the president announces the pick for the new Fed chair three to four months ahead of time.</li>
<li>President Trump is planning to announce his pick as early as this summer or early fall.</li>
<li>The belief is that by announcing his pick so early, President Trump will make Powell miserable enough that Powell will do whatever President Trump wants.</li>
<li>Momo gurus are cheering that President Trump will take away the Fed's independence and the new Fed chair will be President Trump's puppet.</li>
<li>A puppet Fed chair will dramatically cut interest rates, running up the stock market much higher in the short to medium term.&nbsp;&nbsp;</li>
</ul>
</li>
<li>As the momo crowd celebrates, prudent investors should make money from the short to medium term moves in the stock market but be very concerned for the long term if the Fed loses its independence.&nbsp;&nbsp;</li>
<li>Foreign investors are already very concerned.</li>
<li>The dollar hit three year lows on concerns about a puppet Fed chair.&nbsp; If most of your wealth is in dollars, you need to take steps to protect your wealth.&nbsp; The steps include investing in foreign markets, foreign currencies, gold, and other commodities. </li>
<li>Initial jobless claims came at 236K vs. 247K consensus. This data indicates that for the time being the jobs picture is strong.&nbsp; It is worth a reminder that the jobs picture drops off very quickly when the economy slows down.&nbsp; Initial jobless claims is a leading indicator and carries heavy weight in the adaptive <a href="https://thearorareport.com/ALLOCATION%2BMODELS.htm">ZYX Asset Allocation Model</a> with inputs in <a href="https://thearorareport.com/unique-zyx-asset-allocation-4/">ten categories</a>.</li>
<li>Durable orders data is strong. 
<ul class="wp-block-list">
<li>Durable orders came in at 16.4% vs 6.6% consensus.</li>
<li>Durable orders ex-transport came at 0.5% vs 0.1% consensus.</li>
<li>In our analysis, durable orders is a volatile series, and investors should not assign significant meaning to the strength here.</li>
</ul>
</li>
<li>Q1 GDP-third estimate came at -0.5% vs. -0.2% consensus.  In our analysis, this should concern prudent investors as it indicates a slowing economy.</li>
<li>Q1 GDP deflator-third estimate came at 3.8% vs. 3.7% consensus.</li>
<li>PCE, the Fed's favorite inflation gauge, will be released tomorrow at 8:30am ET.   In our analysis, PCE will likely come inline with expectations.  The consensus for headline PCE is 0.1% and 0.1% for core PCE.</li>
<li>Personal income and personal spending data will also be released tomorrow at 8:30am ET.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), and NVIDIA Corp (NVDA).
In the early trade, money flows are neutral in Apple Inc (AAPL).
In the early trade, money flows are negative in Tesla Inc (TSLA).
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">Arora Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary Protection Band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Long Ideas

Market Summary

Broad U.S. Equity ETFs

Politics

Forex

Opinion

Federal Reserve

Markets

Nvidia's New High Shows More Room For AI Trade, Buying On Trump's Move To Make Powell Miserable

Raymond James analyst David Feaster maintains Glacier Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBCI#NYSE">GBCI</a>) with a Outperform and raises the price target from $45 to $48.

GBCI

Raymond James Maintains Outperform on Glacier Bancorp, Raises Price Target to $48

SCCO

Shares of copper stocks are trading higher as copper prices rise amid a drop in the dollar, reports of tight supply and bullish price outlook from Goldman Sachs.

EHLD

Euroholdings shares are trading higher following Q1 reported financial results.

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Alto Neuroscience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANRO#NYSE">ANRO</a>) with a Buy and maintains $10 price target.

Reiteration

ANRO

HC Wainwright & Co. Reiterates Buy on Alto Neuroscience, Maintains $10 Price Target

<a href="https://techcrunch.com/2025/06/26/meta-hires-key-openai-researcher-to-work-on-ai-reasoning-models/" title="https://techcrunch.com/2025/06/26/meta-hires-key-openai-researcher-to-work-on-ai-reasoning-models/">https://techcrunch.com/2025/06/26/meta-hires-key-openai-researcher-to-work-on-ai-reasoning-models/</a>

Management

'Meta Hires Key OpenAI Researcher To Work On AI Reasoning Models' - TechCrunch

ASBP

Aspire Biopharma shares are trading higher on possible continued strength after the company announced on Tuesday that its last patient was dosed for its Phase 1 single-center clinical study of its oral transmucosal fast-acting high-dose aspirin formulation.

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) with a Buy and maintains $5 price target.

IVVD

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $5 Price Target

Raymond James analyst Srini Pajjuri maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Outperform and raises the price target from $120 to $150.

Raymond James Maintains Outperform on Micron Technology, Raises Price Target to $150

ImmunoPrecise Antibodies shares are trading higher on possible continued strength after the company announced on Tuesday its AI-discovered dengue vaccine is safe and triggers an immune response.

Vor Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) saw its stock climb Thursday following a strategic licensing agreement and a major capital raise to support its <a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener">push into autoimmune therapies</a>.
The developments mark a pivotal evolution for the Cambridge-based biotech, which was originally launched by PureTech Health plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>).
Vor Bio signed an exclusive global licensing deal with RemeGen Co., Ltd., giving it rights outside Greater China to develop and commercialize telitacicept, a dual-action fusion protein already approved in <a href="https://www.benzinga.com/pressreleases/25/06/b46108474/puretech-founded-entity-vor-bio-announces-exclusive-global-license-agreement-with-remegen-for-late" target="_blank" rel="noreferrer noopener">China for multiple autoimmune disorders</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/46113313/top-3-health-care-stocks-youll-regret-missing-this-quarter-2" rel="noreferrer noopener">Top 3 Health Care Stocks You&#8217;ll Regret Missing This Quarter</a>
Under the agreement, Vor will pay $125 million upfront, $45 million in cash, and $80 million in stock warrants, along with potential milestone payments exceeding $4 billion and tiered royalties.
Alongside the licensing news, Vor announced on Wednesday a private placement in public equity, which is expected to raise roughly <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g46104566/vor-bio-announces-175-million-private-placement" rel="noreferrer noopener">$175 million in gross proceeds</a>.
The financing involves the issuance of 700 million pre-funded warrants at $0.25 each, with shares exercisable at $0.0001 upon shareholder approval. The transaction is anticipated to close on June 27, pending standard conditions.
On Thursday, Wedbush analyst David Nierengarten reiterated a Neutral rating on the company, and maintained <a target="_blank" href="https://www.benzinga.com/quote/VOR/analyst-ratings" rel="noreferrer noopener">a&nbsp;40 cents&nbsp;price forecast</a>.
Meanwhile, biotech veteran Jean-Paul Kress, M.D. has stepped in as CEO and Chairman of the company, replacing Dr. Robert Ang, who will stay on as a strategic advisor through October.
Kress brings decades of executive experience, including past roles at MorphoSys, Syntimmune, and current board service at Sanofi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>).
He expressed enthusiasm for leading Vor through its transition into a leading autoimmune innovator. As of May 8, PureTech held a 2.1% beneficial ownership stake in Vor Bio, reflecting its founding role in the company.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, VOR stock has lost over 30% in the past year.
Price Action: VOR shares are trading higher by 112.8% to $1.18&nbsp;at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/46060176/donald-trump-jr-joins-mark-cuban-in-slamming-elizabeth-warren-on-healthcare-pricing" target="_blank" rel="noreferrer noopener">Donald Trump Jr. Joins Mark Cuban In Slamming Elizabeth Warren on Healthcare Pricing</a></li>
</ul>
Photo byv jittawit21 via Shutterstock

Equities

Health Care

General

PRTC

Why This Biotech Stock Just Doubled In A Single Day

IPWR

Ideal Power shares are trading higher after the company announced it received an order from a global tier 1 automotive supplier for B-TRAN devices.

Raymond James analyst Steve Moss initiates coverage on Bankwell Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWFG#NASDAQ">BWFG</a>) with a Market Perform rating.

BWFG

Raymond James Initiates Coverage On Bankwell Finl Gr with Market Perform Rating

Nano Labs shares are trading lower after the company announced a $50 million offering of Class A ordinary stock and warrants.

Shares of QuantumScape Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) are surging again on Thursday, building on Wednesday&#8217;s gains, following a major production announcement.
What To Know: The stock is continuing its <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46098476/quantumscape-stock-is-soaring-wednesday-heres-why">upward momentum</a> Thursday morning after the company revealed the successful integration of its advanced Cobra separator process into its baseline cell production. As of mid-morning, the stock was trading at $6.73, a notable increase from its previous close.
This key manufacturing milestone is a critical step for the solid-state battery developer as it aims for large-scale commercialization. The Cobra process is designed to enable faster, more energy-efficient production of the company&#8217;s proprietary ceramic separators, a core component of its lithium-metal battery technology.
Dr. Siva Sivaram, CEO of QuantumScape, <a href="https://www.benzinga.com/pressreleases/25/06/b46083543/quantumscape-achieves-major-milestone-cobra-separator-process-enters-baseline-production">highlighted</a> the significance of the development, stating, &#8220;By significantly improving throughput and shrinking the equipment footprint, Cobra gives us a powerful path forward for commercializing our next-generation battery technology.&#8221;
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46084743/quantumscape-stock-is-surging-after-the-bell-whats-fueling-the-move">QuantumScape Stock Is Surging After The Bell: What&#8217;s Fueling The Move?</a>
Per QuantumScape, the new process features a 25-fold improvement in heat treatment speed compared to the prior-generation &#8220;Raptor&#8221; process. 
This leap in manufacturing efficiency is crucial for the company&#8217;s goal of establishing a scalable gigafactory production line and is seen by investors as a positive sign for the future of its innovative battery technology.
Analyst Ratings: Following the strong two-day surge, QuantumScape&#8217;s stock is now trading <a href="https://www.benzinga.com/quote/QS/analyst-ratings">well above</a> the most recent price targets set by analysts from firms like Baird and Goldman Sachs. 
Notably, there have not been any public analyst rating or price target revisions since the company&#8217;s pivotal Cobra process announcement sparked the rally earlier this week.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, QS shares are trading higher by 18.6% to $6.73 Thursday morning. The stock has a 52-week high of $9.52 and a 52-week low of $3.40.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46099614/aerovironment-posts-better-than-expected-earnings-joins-quantumscape-bumble-blackberry-and-other-big-stocks-moving-higher-on-wednesday">AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday</a>
<h2 class="wp-block-heading">How To Buy QS Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in QuantumScape&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Courtesy of QuantumScape

Why QuantumScape (QS) Stock Is Exploding Higher This Week

Raymond James analyst Steve Moss initiates coverage on Provident Finl Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFS#NYSE">PFS</a>) with a Strong Buy rating and announces Price Target of $21.

Raymond James Initiates Coverage On Provident Finl Servs with Strong Buy Rating, Announces Price Target of $21

FMFC

Kandal M Venture shares are trading higher on possible continued strength after undergoing an IPO yesterday.

Press Releases

Arm Announces Appointment of Charlotte Eaton as Chief People Officer

Arm Announces Earnings Release Date for Third Quarter Fiscal Year Ended 2025

Arm Announces Appointment of Eric Hayes as Executive Vice President, Operations

Arm Holdings plc Reports Results for the Third Quarter of the Fiscal Year Ended 2025

ARM Holdings Reports Strong Earnings Amid AI Chip Demand Surge

Fintech

Brex Grows Enterprise Business 80% as Anthropic, Arm, Robinhood, ServiceTitan, Sonos, Wiz, and More Select Brex as their Modern Spend Platform

GraniteShares ETFs Announces Name Change and Investment Objectives on some of its Short and Leveraged ETFs

Arm Announces Earnings Release Date for Fourth Quarter and Fiscal Year Ended 2025

Cadence to Acquire Arm Artisan Foundation IP Business

Arm Holdings plc Reports Results for the Fourth Quarter and Fiscal Year Ended 2025

CDNS

COIN

HOOD

MSTR

SONO

TSLA

TTAN

Analog Devices

Astera Labs

Advanced Micro Devices, Inc. - Common Stock

Advanced Micro Devices

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing Two Common Shares)

ASE Technology Holding Co

Broadcom

Credo Technology Group Holding Ltd - Ordinary Shares

Credo Technology Group

First Solar

GLOBALFOUNDRIES

Intel

Lattice Semiconductor Corporation - Common Stock

Lattice Semiconductor

Microchip Technology Incorporated - Common Stock

Microchip Technology

Monolithic Power Systems, Inc. - Common Stock

Monolithic Power Systems

Marvell Tech

MACOM Technology Solutions Holdings, Inc. - Common Stock

MACOM Technology Solns

Micron Technology

NVIDIA

Universal Display Corporation - Common Stock

Universal Display

ON Semiconductor Corporation - Common Stock

ON Semiconductor

Qualcomm

Qorvo

STMicroelectronics

Skyworks Solutions

Taiwan Semiconductor Manufacturing Company Ltd.

Taiwan Semiconductor

Texas Instruments Incorporated - Common Stock

Texas Instruments

United Microelectronics Corporation (NEW) Common Stock

United Microelectronics

Loop Capital

Citigroup

B of A Securities

Raymond James

Barclays

Screenshot 2024-07-09 at 1.55.05 PM

Commodities

CSE:PURR

GLIOF

GOOG

Panther Minerals (OTC: GLIOF) May Be Poised To Benefit Amid Nuclear Power Push For AI Data Center Growth

Comments

ARM Holdings

Noticias

Últimas noticias sobre ARM Holdings (NASDAQ:ARM) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL